These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25264306)

  • 21. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.
    Cullen BL; Hutchinson SJ; Cameron SO; Anderson E; Ahmed S; Spence E; Mills PR; Mandeville R; Forrest E; Washington M; Wong R; Fox R; Goldberg DJ
    J Public Health (Oxf); 2012 Mar; 34(1):14-23. PubMed ID: 22138489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely J; Dore GJ
    Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.
    Bruggmann P
    J Viral Hepat; 2012 Dec; 19(12):829-35. PubMed ID: 23205675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons.
    Martin NK; Hickman M; Miners A; Hutchinson SJ; Taylor A; Vickerman P
    BMJ Open; 2013 Aug; 3(8):. PubMed ID: 23943776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
    Mehta SH; Lucas GM; Mirel LB; Torbenson M; Higgins Y; Moore RD; Thomas DL; Sulkowski MS
    AIDS; 2006 Nov; 20(18):2361-9. PubMed ID: 17117023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature.
    Coats JT; Dillon JF
    Int J Drug Policy; 2015 Nov; 26(11):1050-5. PubMed ID: 26118799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.
    Crawford S; Bath N
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S75-9. PubMed ID: 23884070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
    Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
    J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
    McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
    Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
    Chevaliez S; Wlassow M; Volant J; Roudot-Thoraval F; Bachelard A; Poiteau L; Trabut JB; Hézode C; Bourdel A; Dominguez S
    Open Forum Infect Dis; 2020 Jun; 7(6):ofaa196. PubMed ID: 32617372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population.
    Jafferbhoy H; Miller MH; McIntyre P; Dillon JF
    Epidemiol Infect; 2012 Jun; 140(6):1048-53. PubMed ID: 21854668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots.
    Shepherd SJ; Kean J; Hutchinson SJ; Cameron SO; Goldberg DJ; Carman WF; Gunson RN; Aitken C
    J Clin Virol; 2013 May; 57(1):29-35. PubMed ID: 23369886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hepatitis C virus RNA in dried blood spots.
    Bennett S; Gunson RN; McAllister GE; Hutchinson SJ; Goldberg DJ; Cameron SO; Carman WF
    J Clin Virol; 2012 Jun; 54(2):106-9. PubMed ID: 22418454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
    Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P;
    BMC Infect Dis; 2024 Jan; 24(1):137. PubMed ID: 38287234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME;
    J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.